Travere Therapeutics
The Chief Scientific Officer (CSO) at Travere Therapeutics provides strategic scientific leadership to the executive team and board, serving as the primary scientific representative to investors, analysts, academic collaborators, and partners. Reporting to the EVP, Head of Research & Development and Chief Medical Officer, the CSO drives the company's scientific vision, innovation strategy, and long‑term research roadmap across discovery to commercialization.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
56% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago